BICYCLE THERAPEUTICS PLC

For the period ended Sep 30, 2024. Filed Oct 31, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Oct 31, 2024

BCYC$3.69-2.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Operations and Comprehensive Loss

(In thousands, except share and per share data)


· · Three Months Ended · · Nine Months Ended
· · September 30, · · September 30,
· 2024 · 2023 · 2024 · 2023
Collaboration revenues	$2,676	$5,352	$31,567	$21,645
Operating expenses:
Research and development	48,265	39,868	123,188	111,799
General and administrative	18,257	16,281	50,588	45,557
Total operating expenses	66,522	56,149	173,776	157,356
Loss from operations	(63,846)	(50,797)	(142,209)	(135,711)
Other income (expense):
Interest and other income	10,583	3,985	23,981	7,726
Interest expense	(33)	(814)	(1,678)	(2,443)
Loss on extinguishment of debt	(954)	—	(954)	—
Total other income, net	9,596	3,171	21,349	5,283
Net loss before income tax provision	(54,250)	(47,626)	(120,860)	(130,428)
(Benefit from) provision for income taxes	(3,448)	2,272	(3,683)	1,137
Net loss	$(50,802)	$(49,898)	$(117,177)	$(131,565)
Net loss per share, basic and diluted	$(0.74)	$(1.26)	$(2.15)	$(3.95)
Weighted average ordinary shares outstanding, basic and diluted	68,988,858	39,576,467	54,566,490	33,291,701

Comprehensives loss:
Net loss	$(50,802)	$(49,898)	$(117,177)	$(131,565)
Other comprehensive income:
Foreign currency translation adjustment	(2,093)	3,762	(1,881)	2,498
Total comprehensive loss	$(52,895)	$(46,136)	$(119,058)	$(129,067)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.